VRNA
Verona Pharma
VRNA
VRNA
14 hedge funds and large institutions have $132M invested in Verona Pharma in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.32%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
2
Increased
5
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
PA
1
Perceptive Advisors
New York
|
$1.12M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $29.9M | 1,492,951 | – | – |
|
|
O
2
OrbiMed
New York
| $25M | 1,250,396 | – | – |
|
|
NMC
3
NEA Management Company
Timonium,
Maryland
| $24.4M | 1,219,674 | – | – |
|
|
VP
4
venBio Partners
San Francisco,
California
| $17.5M | 875,000 | – | – |
|
|
NHAS
5
Novo Holdings A/S
Hellerup,
Denmark
| $14.8M | 740,740 | – | – |
|
|
FCMI
6
Foresite Capital Management III
Larkspur,
California
| $11.3M | 565,292 | +36,870 | +7% |
|
|
TCM
7
Tekla Capital Management
Boston,
Massachusetts
| $5.5M | 275,000 | – | – |
|
|
PC
8
Polar Capital
London,
United Kingdom
| $2M | 100,000 | +4,851 | +5% |
|
|
PA
9
Perceptive Advisors
New York
| $1.12M | 56,168 | -143,832 | -72% |
|
10
US Bancorp
Minneapolis,
Minnesota
| $77K | 3,840 | +3,840 | New |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $34K | 1,701 | +1,101 | +184% |
|
12
UBS Group
Zurich,
Switzerland
| $14K | 703 | +702 | +70,200% |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $9K | 470 | +470 | New |
|
14
Morgan Stanley
New York
| $4K | 201 | +186 | +1,240% |
|